Latest Tokyo Brief coverage on KOBAYASHI PHARMACEUTICAL CO.,LTD., tracking filings, financial news, and market signals from Japan.
TSE:4967
Japan's consumer-health group says affiliates of buyout firms NSSK and CVC Capital Partners have made a non-binding joint proposal to take it private, confirming a claim from media reports the company itself never issued.
Oasis Management now holds 14.41 percent of Kobayashi Pharmaceutical and has told regulators it may propose dismissing the representative director, changing the board, delisting the company, or clearing the way for an outside buyer to take majority control within 12 months, none of which has been agreed or announced.
Current holdings disclosed by tracked funds.